Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,141 public trials 305 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Acalabrutinib in Patients With Relapsed/Refractory and Treatment naïve Deletion 17p CLL/SLL

NCT02337829

Conditions: Chromosome 17 deletion, Chronic Disease, Chronic Lymphocytic Leukemia, +18 more
Locations: Research Site Bethesda, Maryland, United States

View Trial Details

Completed

Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression

NCT03480360

Conditions: Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +33 more
Locations: Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center Lebanon, New Hampshire, United States

View Trial Details

Completed

Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins

NCT01563874

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: National Cancer Institute (NCI), 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Exosomes and Immunotherapy in Non-Hodgkin B-cell Lymphomas

NCT03985696

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: University Hospital Limoges Limoges, France

View Trial Details

Completed

Evaluation of the Safety of Cytokine-Induced-Killer Cells During Early Transplant Period of Autologous Hematopoietic Stem Cell Transplant Recipients.

NCT07692607

Conditions: Autologous Hematopoietic Stem Cell Transplant, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: The Catholic University of Korea Seoul St.Mary's Hospital Seoul, South Korea

View Trial Details

Completed

A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma

NCT04837222

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Anhui Provincial Cancer Hospital Hefei, Anhui, China

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

Peking University People's Hospital Beijing, Beijing Municipality, China

Peking University Third Hospita Beijing, Beijing Municipality, China

View all 32 locations

View Trial Details

Completed

Pilot Study of an NTproBNP Guided Strategy of Cardioprotection

NCT04737265

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +23 more
Locations: City of Hope Duarte, California, United States

Abramson Cancer Center at University of Pennsylvania Philadelphia, Pennsylvania, United States

Chester County Hospital West Chester, Pennsylvania, United States

View Trial Details

Completed

Efficacy and Safety of Oral Azacitidine (CC-486) Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory Angioimmunoblastic T Cell Lymphoma

NCT03703375

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Local Institution - 41822 Sapporo, Hokkaido, Japan

Local Institution - 41922 Okayama, Okayama-ken, Japan

Local Institution - 41722 Sayama, Osaka, Japan

Local Institution - 41422 Hidaka, Saitama-Pref, Japan

View Trial Details

Completed

Feasibility of an Adapted Sports Program Based on Fencing to Reduce Physical Deconditioning in Adult Hematology Patients

NCT06026046

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: University Hospital, Angers Angers, France

University Brest Hopspital Brest, France

View Trial Details

Completed

CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies

NCT04088864

Conditions: Acute Lymphoblastic Leukemia, Pediatric, B Cell Lymphoma, Hematologic Diseases, +13 more
Locations: Stanford Medical Center Stanford, California, United States

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions